RD Rubens

2.2k total citations · 1 hit paper
16 papers, 1.7k citations indexed

About

RD Rubens is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, RD Rubens has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in RD Rubens's work include Cancer Treatment and Pharmacology (5 papers), Bone health and treatments (4 papers) and Breast Cancer Treatment Studies (4 papers). RD Rubens is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Bone health and treatments (4 papers) and Breast Cancer Treatment Studies (4 papers). RD Rubens collaborates with scholars based in United Kingdom, Switzerland and Portugal. RD Rubens's co-authors include RE Coleman, MA Richards, Penella J. Woll, M. P. Miles, Ketan Patel, DM Barnes, RS Camplejohn, Frank J. Godinho, R R Millis and Rosalind Graham and has published in prestigious journals such as British Journal of Cancer, British Journal of Clinical Pharmacology and International Journal of Clinical Practice.

In The Last Decade

RD Rubens

16 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The clinical course of bone metastases from breast cancer

1987 869 citations RE Coleman, RD Rubens British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RD Rubens United Kingdom	16	1.3k	572	419	341	316	16	1.7k
Ian Kennedy New Zealand	14	1.7k 1.3×	629 1.1×	477 1.1×	392 1.1×	279 0.9×	21	2.2k
N. Davidson United Kingdom	15	1.3k 1.0×	288 0.5×	357 0.9×	501 1.5×	358 1.1×	41	1.9k
Norio Kohno Japan	23	972 0.7×	323 0.6×	255 0.6×	260 0.8×	396 1.3×	89	1.5k
Richard H. De Boer Australia	15	1.7k 1.3×	363 0.6×	669 1.6×	297 0.9×	539 1.7×	48	2.1k
Michela Donadio Italy	23	1.1k 0.8×	249 0.4×	330 0.8×	258 0.8×	352 1.1×	68	1.8k
J. Vinholes United Kingdom	16	2.1k 1.6×	906 1.6×	1.0k 2.4×	365 1.1×	251 0.8×	37	2.6k
Rosa Fonti Italy	23	560 0.4×	387 0.7×	276 0.7×	137 0.4×	489 1.5×	65	1.6k
Marcello Tucci Italy	24	748 0.6×	593 1.0×	1.3k 3.2×	243 0.7×	403 1.3×	100	1.9k
Winnie Sohn United States	13	686 0.5×	271 0.5×	510 1.2×	324 1.0×	283 0.9×	26	1.5k
Mark George United Kingdom	16	649 0.5×	546 1.0×	157 0.4×	387 1.1×	410 1.3×	33	1.5k

Countries citing papers authored by RD Rubens

Since Specialization

Citations

This map shows the geographic impact of RD Rubens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RD Rubens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RD Rubens more than expected).

Fields of papers citing papers by RD Rubens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RD Rubens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RD Rubens. The network helps show where RD Rubens may publish in the future.

Co-authorship network of co-authors of RD Rubens

This figure shows the co-authorship network connecting the top 25 collaborators of RD Rubens. A scholar is included among the top collaborators of RD Rubens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RD Rubens. RD Rubens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Rubens, RD. (2001). 7. MANAGEMENT OF ADVANCED BREAST CANCER. International Journal of Clinical Practice. 55(10). 676–679. 15 indexed citations

2.

Miles, D.W., et al.. (1996). A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer. British Journal of Cancer. 74(8). 1292–1296. 92 indexed citations

3.

Twelves, C.J., David A. Porter, M. Lowry, et al.. (1994). Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. British Journal of Cancer. 69(6). 1151–1156. 25 indexed citations

4.

Twelves, C.J., et al.. (1994). Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life. British Journal of Cancer. 69(4). 726–731. 18 indexed citations

5.

Patel, Ketan, et al.. (1994). The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. British Journal of Cancer. 70(2). 335–341. 115 indexed citations

6.

Hill, ME, MA Richards, WM Gregory, Paul Smith, & RD Rubens. (1993). Spinal cord compression in breast cancer: a review of 70 cases. British Journal of Cancer. 68(5). 969–973. 51 indexed citations

7.

Houston, Stephen, et al.. (1992). Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. British Journal of Cancer. 65(5). 766–768. 61 indexed citations

8.

Rubens, RD, et al.. (1991). Phase II trial of didox in advanced breast cancer. British Journal of Cancer. 64(6). 1187–1188. 27 indexed citations

9.

Camplejohn, RS, et al.. (1990). DNA index, S-phase fraction, histological grade and prognosis in breast cancer. British Journal of Cancer. 61(5). 671–674. 99 indexed citations

10.

Twelves, C.J., et al.. (1989). Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry. British Journal of Cancer. 60(6). 938–941. 26 indexed citations

11.

Coleman, RE, et al.. (1988). Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). British Journal of Cancer. 58(5). 621–625. 107 indexed citations

12.

Coleman, RE, et al.. (1988). Biochemical prediction of response of bone metastases to treatment. British Journal of Cancer. 58(2). 205–210. 71 indexed citations

13.

Coleman, RE & RD Rubens. (1987). 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer. British Journal of Cancer. 56(4). 465–469. 43 indexed citations

14.

Godinho, Frank J., et al.. (1987). A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma. British Journal of Cancer. 56(4). 471–473. 98 indexed citations

15.

Coleman, RE & RD Rubens. (1987). The clinical course of bone metastases from breast cancer. British Journal of Cancer. 55(1). 61–66. 869 indexed citations breakdown →

16.

Adam, Ana-Maria, et al.. (1984). The effect of acetylator phenotype on the disposition of aminoglutethimide.. British Journal of Clinical Pharmacology. 18(4). 495–505. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact